Use of c-peptide and autoantibodies in individuals clinically labelled as Type 1 to identify those likely to have Type 2 diabetes

DIABETIC MEDICINE(2019)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要